Based on the PKD model caused by the oncogene MYC, SETD2 deficiency accelerates the transition from PKD to RCC by regulating β‐catenin activity at the transcriptional and post‐transcriptional levels.26 This evidence concerns the gene MYC and renal cell adenocarcinoma.